News

Harvard Medical School: COVID-19 Resources for Providers

  The Harvard Medical School is releasing a series of educational videos covering the COVID-19 pandemic. This initiative started on April 2020 and was designed especially for physicians, nurses and other health care providers. COVID-19 continues to change many aspects of clinical management and health care, for this reason Harvard Medical School (HMS) is providing

October 30th, 2020|

EJP RD: JOINT TRANSNATIONAL CALL 2021

An early announcement of the joint transnational call 2021 has been published on EJP RD website. In order to improve healthcare system and ordinary life of people that live with rare diseases, this call has the aim to encourage research on Social Sciences and Humanities (SSH). Of high relevance during the call, as it can

October 28th, 2020|

EJP RD: Short guide on patient partnership in rare disease research projects

The European Joint Programme on Rare Diseases (EJP RD) has developed, together with a working group led by EURORDIS, named Patient Engagement in Biomedical Research Projects (PENREP), a short guide on Patient Partnership in rare disease research projects. The main goal of this project, as stated in the guide, is to encourage a prolific and

October 28th, 2020|

SAVE THE DATE. 2-4 November, 2020. Clinical Trials Europe 2020

The Clinical Trials Europe is the Europe's largest event dedicated to streamlining clinical trials and improving patient outcomes. The 2020 Edition will take place virtually on 2-4 November due to covid-19 pandemic. The agenda will foresee 6 conference streams and 2 plenaries that will provide the occasion to bring together collaborative stakeholders, key associations dedicated

October 20th, 2020|

SAVE THE DATE: 30-11-2020. Workshop on support for orphan medicines development

The Committee for Orphan Medicinal Product (COMP) of the European Medicines Agency (EMA) will organise a Workshop on support for orphan medicines development on 30 November 2020. The virtual event aims to encourage early and efficient interactions with the regulators by highlighting pre-marketing support in medicine development in rare diseases. Existing tools such as orphan

October 12th, 2020|

SAVE THE DATE. 23.10.2020. XIII FORESIGHT TRAINING COURSE: CHALLENGES FOR RESEARCHERS AND REGULATORS FACING THE PANDEMIC CRISIS

The XIII Foresight Training Course (FTC) will be held virtually on 23 October 2020. Annually, Fondazione Gianni Benzi organises the Foresight Training Course (FTC), a short international course aimed to promote pharmacological research and innovation. This year, due to the COVID-19 restrictions enforced, the XIII FTC will run virtually in a shorter version and will

October 1st, 2020|

Annagrazia ALTAVILLA, Chair of TEDDY, appointed as consultant/expert of the Council of Europe for children focused activities foreseen in the new COE “Strategic Action Plan on Human Rights and Technologies in Biomedicine”

Annagrazia ALTAVILLA, Chair of TEDDY, has been appointed as consultant/expert of the Council of Europe - Bioethics Division, within the new DH -BIO Strategic Action Plan on Human Rights and Technologies in Biomedicine (2020-2025). This plan provides specific considerations on children and paediatric population, underlining that important human rights challenges are also emerging through established

September 29th, 2020|

Public consultation on European Medicines Agencies Network Strategy to 2025

The European medicines regulatory network (EMRN) represents a unique response to the challenge of regulating human and veterinary medicines across a diverse group of countries. It includes the national competent authorities (NCAs) of the 27 EU Member States plus those of Iceland, Liechtenstein and Norway, and also come together under the aegis of the Heads

September 29th, 2020|

Good Lay Summary Practice: TEDDY answered to the Public Consultation

The upcoming Clinical Trial Regulation requires the development and dissemination of Lay Summaries of clinical study results from commercial and non-commercial sponsors. However, there is no guidance for all types of sponsors on how best to handle the development process of Lay Summaries and how best to ensure reliable dissemination so that the ultimate goals

September 29th, 2020|